The Beneluxa Initiative strives to expand sustainable access for patients to high-quality affordable treatments. For this reason, the members of the Beneluxa Initiative welcome the proposed Critical Medicines Act, as it contributes to our shared goals. The members of the Beneluxa...
The Beneluxa Initiative aims to ensure sustainable access
to innovative medicine at affordable cost for our patients.
Beneluxa Initiative and the Critical Medicines Act
From Assessment to Appraisal: Beneluxa Initiative hosts meeting with Advisory Bodies on Medicines Reimbursement
On 6 May 2025, the Beneluxa Initiative organised a meeting that brought together representatives from the Belgian and Dutch advisory bodies on medicines reimbursement: the CRM (Commission for the Reimbursement of Medicines, Belgium), WAR (Scientific Advisory Board, Netherlands)...
Steering Committee Meeting in Vienna, Austria
Today, the Steering Committee of the Beneluxa Initiative convened in Vienna, Austria, for its bi-annual meeting, bringing together representatives from member countries to discuss progress, priorities, and future strategy. The agenda covered a range of key topics, including...